newsfilter
← Latest News
PR Newswire·

Nuo Therapeutics Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid Services

HOUSTON, April 20, 2021 /PRNewswire/ -- Nuo Therapeutics, Inc. (OTC:AURX) ("Nuo" or the "Company"), today announced the recent publication of the final decision memo for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (CAG-00190R4). O